Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; Results from the European prospective investigation into cancer and nutrition (pages 2656–2664)Anne E. Cust, Naomi E. Allen, Sabina Rinaldi, Laure Dossus, Christine Friedenreich, Anja Olsen, Anne Tjønneland, Kim Overvad, Françoise Clavel-Chapelon, Marie-Christine Boutron-Ruault, Jakob Linseisen, Jenny Chang-Claude, Heiner Boeing, Mandy Schulz, Vassiliki Benetou, Antonia Trichopoulou, Dimitrios Trichopoulos, Domenico Palli, Franco Berrino, Rosario Tumino, Amalia Mattiello, Paolo Vineis, J. Ramón Quirós, Antonio Agudo, Maria-Jose Sánchez, Nerea Larrañaga, Carmen Navarro, Eva Ardanaz, H. Bas Bueno-de-Mesquita, Petra H.M. Peeters, Carla H. van Gils, Sheila Bingham, Kay-Tee Khaw, Tim Key, Nadia Slimani, Elio Riboli and Rudolf Kaaks
Article first published online: 6 FEB 2007 | DOI: 10.1002/ijc.22578